VMP 42212911000001108

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Lacidipine 4mg tablets
BNF code 0206020K0AAABAB
Virtual Therapeutic Moiety Lacidipine
Date identifier became valid 1 Sep 2023
Previous product identifier 319301007
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Lacidipine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 4.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Lacidipine 4mg tablets (A A H Pharmaceuticals Ltd)
Lacidipine 4mg tablets (Alliance Healthcare (Distribution) Ltd)
Lacidipine 4mg tablets (Dr Reddy's Laboratories (UK) Ltd)
Lacidipine 4mg tablets (Medihealth (Northern) Ltd)
Lacidipine 4mg tablets (Sigma Pharmaceuticals Plc)
Lacidipine 4mg tablets (Viatris UK Healthcare Ltd)
Lacidipine 4mg tablets (Zentiva Pharma UK Ltd)
Molap 4mg tablets (Rivopharm (UK) Ltd)
Motens 4mg tablets (GlaxoSmithKline UK Ltd)
Virtual Medicinal Product Packs
Lacidipine 4mg tablets 14 tablet
Lacidipine 4mg tablets 28 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.4.0_20240429000001, imported on 29th April 2024 at 05:07:25.

Feedback